Stock UniverseDerived research view · source repositories remain read-only

iBio, Inc. (IBIO)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
20.57
Global Rank
3281
Market Cap
97.41M
Latest Close
1.82
RS Composite
-24.28% · G#2831

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
2.82%
3M
-30.27%
6M
75.00%
1Y
83.84%
3Y
-87.00%
5Y
-99.75%
10Y
-99.95%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 2.28M · 30-day average: 997.16K · Max drawdown over stored range: -99.98%

Research Snapshot

Relative Strength vs SPX

RS Composite-24.28%
20D RS10.34%
60D RS-34.08%
120D RS-31.79%
Global RS Rank2831 · 15.62% percentile
Watch+Speculative RS Rank1732 · 17.41% percentile
Group ScopeWatch+Speculative
Primary RS Rank331 · 27.73% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank440 / 701
Primary Percentile37.38
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for IBIO.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue2.3711.88400.2250.4
Revenue Growth (YoY)44.75%-20.54%2900%2900%77.778%
Gross Profit0.9091.88400.2250.4
Operating Income-30.968-29.697-28.778-16.634-18.602
Free Cash Flow-34.984-44.81-36.866-18.764-15.32
Free Cash Flow Per Share-89.416-102.763-60.239-4.898-1.459
EPS (Diluted) GAAP-59.979552-115.562435-106.22549-6.501435-1.750357
EPS Growth
EPS Non-GAAP
Gross Margin38.338%100%2900%100%100%
Operating Margin-1306.116%-1576.274%2900%-7392.889%-4650.5%
Profit Margin-989.751%-2674.682%2900%-11069.778%-4594.25%
Free Cash Flow Margin-1475.496%-2378.45%2900%-8339.556%-3830.0%
Shares Outstanding (Diluted)0.39120.4360.6123.83110.499
Shares Change (YoY)211.53%11.45%40.351%525.98%174.054%

SEC Quarterly Fundamentals

No processed quarterly rows for IBIO.